4/A

FORM 4/A SUBMISSION

Company: AMICUS THERAPEUTICS, INC.
Filed: October 20, 2017
Period of Report: October 17, 2017
Accession Number: 0001209191-17-057662

View Document ↗ View on SEC.gov ↗